Four novel FXI gene mutations in three factor XI-deficient patients

被引:4
作者
de Raucourt, Emmanuelle [1 ]
de Mazancourt, Philippe [2 ,3 ]
Quelin, Florence [2 ,3 ]
机构
[1] Univ Versailles, Haematol Lab, St Quentin en Yvelines, France
[2] Univ Versailles, Poissy Saint Germainen Laye Hosp, Biochem Lab, St Quentin en Yvelines, France
[3] Univ Versailles, UPRES, EA2493, St Quentin en Yvelines, France
关键词
factor XI deficiency; novel mutation; rare bleeding disorder;
D O I
10.1097/MBC.0b013e3282f6d256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary factor XI deficiency is a mild bleeding disorder, which is highly prevalent among Ashkenazi Jews, but has been reported in all populations. In Ashkenazi Jews, two factor XI gene mutations Glu 117X (type II) and Phe283Leu (type 111) are particularly common. In other ethnic groups, factor XI deficiency is a rare bleeding disorder and is related to a variety of mutations throughout the factor XI gene. Three cases of quantitative factor XI deficiency in relation with four novel missense mutations are reported: a compound heterozygosity for two novel mutations (Ala 181 Val and Ala 412 Thr) with a severe factor XI deficiency and two missense mutations (His 388 Pro and Trp 407 Cys) in heterozygous patients with partial factor XI deficiency. Blood Coagul Fibrinolysis 19:240-242 (c) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:240 / 242
页数:3
相关论文
共 9 条
[1]   FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL [J].
ASAKAI, R ;
CHUNG, DW ;
DAVIE, EW ;
SELIGSOHN, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :153-158
[2]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[3]   FACTOR-XI ACTIVATION IN A REVISED MODEL OF BLOOD-COAGULATION [J].
GAILANI, D ;
BROZE, GJ .
SCIENCE, 1991, 253 (5022) :909-912
[4]   A classification system for cross-reactive material-negative factor XI deficiency [J].
Kravtsov, DV ;
Monahan, PE ;
Gailani, D .
BLOOD, 2005, 105 (12) :4671-4673
[5]  
MAGG PHB, 2004, HAEMOPHILIA, V1, P593
[6]  
MEJERS J, 1992, BLOOD, V79, P1435
[7]   Heterozygous factor XI deficiency associated with three novel mutations [J].
Mitchell, M ;
Cutler, J ;
Thompson, S ;
Moore, G ;
ap Rees, EJ ;
Smith, M ;
Savidge, G ;
Alhaq, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (04) :763-765
[8]   Crystal structure of the factor XI zymogen reveals a pathway for transactivation [J].
Papagrigoriou, Evangelos ;
McEwan, Paul A. ;
Walsh, Peter N. ;
Emsley, Jonas .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (06) :557-558
[9]   Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy [J].
Salomon, O. ;
Steinberg, D. M. ;
Seligshon, U. .
HAEMOPHILIA, 2006, 12 (05) :490-493